In this regard, the increased vimentin/E-cadherin ratio has been proposed as a hallmark of EMT changes in CRC cells [38], which may help in monitoring malignancy [39] and patient prognosis [40]. The gene discussed is CDH1; the disease is colorectal carcinoma.